Catalyst Events and Market Watch Significant upcoming catalyst events include the phase [name] readout of Eli Lillys glipron, which will indicate the efficacy of oral GLP-1s, followed by Pfizers glipron and other oral GLP-1s by 2028
Pathway 1: Reducing Pain and Inflammation This is the big one
144, no
Reville PK, MD, MPH, Kantarjian H, MD, Borthakur G, MD, Pemmaraju N, MD, DiNardo CD, MD, MSCE, Sasaki K, MD, PhD, Daver N, MD, Issa GC, MD, Ohanian M, DO, Montalban-Bravo G, MD, Short NJ, MD, Jain N, MD, Bhalla KN, MD, Jabbour EJ, MD, Ferrajoli A, MD, Takahashi K, MD, PhD, Rausch CR, PharmD, Malla R, RN, BSN, Marek K, Brandt M, BS, Popat UR, MD, Andreeff M , MD, PhD, Garcia-Manero G, MD, Konopleva M, MD, PhD, Ravandi F, MBBS, Kadia TM, MD
Why We Picked Them: John Kocka, MD & Rachel Budd, NP leads the clinical team
Both can be powerful tools when used intentionally and in the right context